Marshall Wace
SNY icon

Marshall Wace’s Sanofi SNY Stock Holding History

Marshall Wace’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,822
Closed -$429K – 2825
2020
Q4 		$429K Buy
+8,822
New +$435K ﹤0.01% 1520
2020
Q3 		– Sell
-27,609
Closed -$1.41M – 1902
2020
Q2 		$1.41M Buy
+27,609
New +$1.34M 0.01% 907
2020
Q1 		– Sell
-390,118
Closed -$19.6M – 2031
2019
Q4 		$19.6M Buy
390,118
+238,189
+157% +$11.2M 0.13% 172
2019
Q3 		$7.04M Buy
+151,929
New +$6.55M 0.06% 395
2018
Q3 		– Sell
-42,107
Closed -$1.69M – 1271
2018
Q2 		$1.69M Buy
+42,107
New +$1.66M 0.03% 447
2014
Q4 		– Sell
-20,080
Closed -$1.13M – 950
2014
Q3 		$1.13M Buy
+20,080
New +$1.08M 0.02% 534

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Marshall Wace's SNY Position: Q1 2021 in Review

Marshall Wace sold out of Sanofi (SNY) in Q1 2021, closing a stake of 8,822 shares — an estimated $429K sold.

Marshall Wace first reported a position in SNY in Q3 2014 and held it in 6 quarters. The position peaked at $19.6M in Q4 2019. 573 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • Marshall Wace reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace sold 8,822 Sanofi shares in Q1 2021, an estimated $429K.
  • Marshall Wace first reported a position in Sanofi in Q3 2014 and held it in 6 quarters.
  • Marshall Wace's Sanofi position peaked at $19.6M in Q4 2019.
  • 573 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.